L Fraenkel

Summary

Affiliation: Yale University
Country: USA

Publications

  1. pmc Patient treatment preferences for osteoporosis
    Liana Fraenkel
    Yale University School of Medicine, Section of Rheumatology, New Haven, CT 06520 8031, USA
    Arthritis Rheum 55:729-35. 2006
  2. pmc Incorporating patients' preferences into medical decision making
    Liana Fraenkel
    Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520 8031, USA
    Med Care Res Rev 70:80S-93S. 2013
  3. pmc Decision tool to improve the quality of care in rheumatoid arthritis
    Liana Fraenkel
    Yale University School of Medicine, Section of Rheumatology, 300 Cedar Street, TAC 525, PO Box 208031, New Haven, CT 06520 8031, USA
    Arthritis Care Res (Hoboken) 64:977-85. 2012
  4. pmc Measuring pain impact versus pain severity using a numeric rating scale
    Liana Fraenkel
    VA CT Healthcare System, Yale University School of Medicine, New Haven, CT 06520, USA
    J Gen Intern Med 27:555-60. 2012
  5. pmc Are rheumatologists' treatment decisions influenced by patients' age?
    L Fraenkel
    Department of Medicine, VA Connecticut Healthcare System, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520 8031, USA
    Rheumatology (Oxford) 45:1555-7. 2006
  6. pmc Patient willingness to take teriparatide
    Liana Fraenkel
    VA Connecticut Healthcare System, USA
    Patient Educ Couns 65:237-44. 2007
  7. pmc What are the essential elements to enable patient participation in medical decision making?
    Liana Fraenkel
    VA Connecticut Healthcare System, West Haven, CT 06516, USA
    J Gen Intern Med 22:614-9. 2007
  8. ncbi request reprint Improving informed decision-making for patients with knee pain
    Liana Fraenkel
    Veterans Affairs Connecticut Healthcare System and the Yale University School of Medicine, New Haven, Connecticut, USA
    J Rheumatol 34:1894-8. 2007
  9. ncbi request reprint Participation in medical decision making: the patients' perspective
    Liana Fraenkel
    VA Connecticut Healthcare System, Yale University School of Medicine, New Haven, Connecticut 06520 8031, USA
    Med Decis Making 27:533-8. 2007
  10. pmc Patients' preferences for treatment of hepatitis C
    Liana Fraenkel
    VA Connecticut Healthcare System and Yale University School of Medicine, New Haven, Connecticut, USA
    Med Decis Making 30:45-57. 2010

Research Grants

Detail Information

Publications47

  1. pmc Patient treatment preferences for osteoporosis
    Liana Fraenkel
    Yale University School of Medicine, Section of Rheumatology, New Haven, CT 06520 8031, USA
    Arthritis Rheum 55:729-35. 2006
    ..To examine patient preferences for currently available and promising osteoporosis treatment options...
  2. pmc Incorporating patients' preferences into medical decision making
    Liana Fraenkel
    Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520 8031, USA
    Med Care Res Rev 70:80S-93S. 2013
    ..We provide case examples to illustrate the potential value of adopting each of these approaches in clinical practice...
  3. pmc Decision tool to improve the quality of care in rheumatoid arthritis
    Liana Fraenkel
    Yale University School of Medicine, Section of Rheumatology, 300 Cedar Street, TAC 525, PO Box 208031, New Haven, CT 06520 8031, USA
    Arthritis Care Res (Hoboken) 64:977-85. 2012
    ..The objective of this study was to develop a decision support tool to inform RA patients with ongoing active disease about the risks and benefits related to biologic therapy...
  4. pmc Measuring pain impact versus pain severity using a numeric rating scale
    Liana Fraenkel
    VA CT Healthcare System, Yale University School of Medicine, New Haven, CT 06520, USA
    J Gen Intern Med 27:555-60. 2012
    ..This may be, in part, due to the failure of the NRS to adequately predict patients' preferences for additional treatment...
  5. pmc Are rheumatologists' treatment decisions influenced by patients' age?
    L Fraenkel
    Department of Medicine, VA Connecticut Healthcare System, Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520 8031, USA
    Rheumatology (Oxford) 45:1555-7. 2006
    ..The objective of this study was to determine whether physicians' treatment preferences are influenced by patients' age...
  6. pmc Patient willingness to take teriparatide
    Liana Fraenkel
    VA Connecticut Healthcare System, USA
    Patient Educ Couns 65:237-44. 2007
    ..The objective of this study was to determine how much benefit women expect teriparatide to confer before agreeing to perform daily injections...
  7. pmc What are the essential elements to enable patient participation in medical decision making?
    Liana Fraenkel
    VA Connecticut Healthcare System, West Haven, CT 06516, USA
    J Gen Intern Med 22:614-9. 2007
    ..Patient participation in shared decision making (SDM) results in increased patient knowledge, adherence, and improved outcomes. Despite the benefits of the SDM model, many patients do not attain the level of participation they desire...
  8. ncbi request reprint Improving informed decision-making for patients with knee pain
    Liana Fraenkel
    Veterans Affairs Connecticut Healthcare System and the Yale University School of Medicine, New Haven, Connecticut, USA
    J Rheumatol 34:1894-8. 2007
    ..The objective of this pilot study was to test the efficacy of a computer tool to improve informed decision-making for patients with knee pain in an outpatient primary care clinic setting...
  9. ncbi request reprint Participation in medical decision making: the patients' perspective
    Liana Fraenkel
    VA Connecticut Healthcare System, Yale University School of Medicine, New Haven, Connecticut 06520 8031, USA
    Med Decis Making 27:533-8. 2007
    ..The authors sought to learn more about how patients view their involvement in decisions related to their health care...
  10. pmc Patients' preferences for treatment of hepatitis C
    Liana Fraenkel
    VA Connecticut Healthcare System and Yale University School of Medicine, New Haven, Connecticut, USA
    Med Decis Making 30:45-57. 2010
    ..The objective of this study was to ascertain patient preferences for treatment of hepatitis C virus (HCV)...
  11. pmc Patient responsibility for medical decision making and risky treatment options
    Liana Fraenkel
    Yale University School of Medicine, New Haven, Connecticut, USA
    Arthritis Rheum 61:1674-6. 2009
    ..The objective of this study was to examine whether emphasizing volition increases patients' risk perception and decreases their willingness to accept risk...
  12. pmc Uncertainty and patients' preferred role in decision making
    Liana Fraenkel
    VA Connecticut Healthcare System, West Haven, USA
    Patient Educ Couns 82:130-2. 2011
    ..The objective of this study was to determine if certainty related to initiating treatment is related to preferred role in decision making...
  13. pmc Patients' reaction to the disclosure of rare dreaded adverse events
    Liana Fraenkel
    Section of Rheumatology, Yale University School of Medicine, New Haven, CT 06520, USA
    Patient Educ Couns 84:e1-4. 2011
    ..Physicians must frequently inform their patients of the risks of rare, but serious, adverse events (AEs)...
  14. pmc Development of a tool to improve the quality of decision making in atrial fibrillation
    Liana Fraenkel
    Department of Medicine, Yale University School of Medicine, New Haven, CT, USA
    BMC Med Inform Decis Mak 11:59. 2011
    ....
  15. ncbi request reprint What do patients consider when making decisions about treatment for hepatitis C?
    Liana Fraenkel
    Department of Medicine, VA Connecticut Healthcare System, West Haven, Conn, USA
    Am J Med 118:1387-91. 2005
    ..In this study, we sought to investigate the factors that influence patients' decisions as they consider treatment for hepatitis C infection...
  16. ncbi request reprint Patients' experiences related to anti-viral treatment for hepatitis C
    Liana Fraenkel
    VA Connecticut Healthcare System, CT, USA
    Patient Educ Couns 62:148-55. 2006
    ..To conduct a qualitative study to elicit patients' descriptions of their own experiences with treatment for hepatitis C (HCV)...
  17. ncbi request reprint Women's preferences for prevention of bone loss
    Liana Fraenkel
    Section of Rheumatology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520 8031, USA
    J Rheumatol 32:1086-92. 2005
    ..Despite the serious consequences of osteoporosis, few women use pharmacologic measures to prevent postmenopausal bone loss. We used an interactive computerized questionnaire to examine women's preferences for prevention of osteoporosis...
  18. pmc Individualized medical decision making: necessary, achievable, but not yet attainable
    Liana Fraenkel
    Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Arch Intern Med 170:566-9. 2010
    ..Improving care for patients with comorbidities will require substantive increases in the efforts and resources allocated to the collection and dissemination of outcome data for patients with varying comorbidities...
  19. ncbi request reprint Are preferences for cyclooxygenase-2 inhibitors influenced by the certainty effect?
    Liana Fraenkel
    VA Connecticut Healthcare System, West Haven, Connecticut 06520 8031, USA
    J Rheumatol 31:591-3. 2004
    ..e., by a perception that COX-2 inhibitors eliminate the risk of serious gastrointestinal (GI) events in contrast to merely reduce their risk...
  20. ncbi request reprint Risk communication in rheumatoid arthritis
    Liana Fraenkel
    VA Connecticut Healthcare System, West Haven, Connecticut 06520 8031, USA
    J Rheumatol 30:443-8. 2003
    ..quot; We investigated whether some patients with rheumatoid arthritis (RA) treat the risk of adverse effects (AE) as "protected values," i.e., as unacceptable regardless of how small the risk...
  21. ncbi request reprint Informed choice and the widespread use of antiinflammatory drugs
    Liana Fraenkel
    Veteran s Affairs Connecticut Healthcare System and Yale University, New Haven, Connecticut, USA
    Arthritis Rheum 51:210-4. 2004
    ..To examine whether the current widespread use of antiinflammatory drugs may reflect a lack of informed choice (i.e., unawareness of adverse effects or potential treatment alternatives) among older patients with knee osteoarthritis (OA)...
  22. pmc Patient preferences for treatment of rheumatoid arthritis
    L Fraenkel
    VA Connecticut Healthcare System, West Haven, CT 06516, USA
    Ann Rheum Dis 63:1372-8. 2004
    ..To elicit treatment preferences of patients with rheumatoid arthritis (RA) for disease modifying antirheumatic drugs (DMARDs) with varying risk profiles...
  23. ncbi request reprint Treatment options in knee osteoarthritis: the patient's perspective
    Liana Fraenkel
    Veterans Affairs Connecticut Healthcare System, West Haven, USA
    Arch Intern Med 164:1299-304. 2004
    ....
  24. ncbi request reprint Understanding patient preferences for the treatment of lupus nephritis with adaptive conjoint analysis
    L Fraenkel
    Department of Medicine, Yale University, New Haven, Connecticut 06520 8031, USA
    Med Care 39:1203-16. 2001
    ..Conjoint analysis is an established method of eliciting consumer preferences in market research and is being increasingly used to study patient preferences for health care...
  25. ncbi request reprint Risk-attitude and patient treatment preferences
    L Fraenkel
    VA Connecticut Health Care System, West Haven, CT 06516, USA
    Lupus 12:370-6. 2003
    ..Our results suggest that patients' relative risk-attitudes, as measured by a lottery task, are related to their treatment preferences. Differences in risk-attitude may help explain the inter-patient variability in treatment preferences...
  26. ncbi request reprint Unwillingness of rheumatoid arthritis patients to risk adverse effects
    L Fraenkel
    Department of Medicine, Yale University, New Haven, CT 06520, VA Connecticut Health Care System, West Haven, CT 06516, USA
    Rheumatology (Oxford) 41:253-61. 2002
    ..To evaluate patient willingness to accept the risk of adverse effects (AEs) commonly associated with arthritis medications...
  27. ncbi request reprint Preference for disclosure of information among patients with rheumatoid arthritis
    L Fraenkel
    Department of Medicine, Yale University, New Haven, Connecticut 06520-8031, USA
    Arthritis Rheum 45:136-9. 2001
    ..The challenge remaining for rheumatologists is how to effectively communicate the risks and benefits related to the many options that are currently available for RA patients...
  28. pmc Preference for hip protectors among older adults at high risk for osteoporotic fractures
    Liana Fraenkel
    Veterans Administration Connecticut Healthcare System and the Yale University School of Medicine, New Haven, Connecticut 06520 8031, USA
    J Rheumatol 33:2064-8. 2006
    ..To determine older adults' treatment preferences for osteoporosis comparing bisphosphonates and hip protectors...
  29. ncbi request reprint Rheumatologists' attitudes toward routine screening for hydroxychloroquine retinopathy
    L Fraenkel
    Yale University, Department of Internal Medicine, Section of Rheumatology, PO Box 208031, 333 Cedar Street, New Haven, CT 06520 8031, USA
    J Rheumatol 28:1218-21. 2001
    ..To examine rheumatologists' attitudes toward routine ophthalmologic screening for hydroxychloroquine (HCQ) retinopathy and to estimate the acceptability of hypothetical guidelines discouraging this practice...
  30. pmc Role of magnetic resonance imaging in the diagnosis and prognosis of rheumatoid arthritis
    Lisa G Suter
    Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA
    Arthritis Care Res (Hoboken) 63:675-88. 2011
    ..To systematically evaluate the literature addressing the role of magnetic resonance imaging (MRI) in the diagnosis and prognosis of early undifferentiated inflammatory arthritis and rheumatoid arthritis (RA)...
  31. pmc Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review
    Una E Makris
    Section of Rheumatology, Yale University School of Medicine, PO Box 208031, 300 Cedar Street, S 525 TAC, New Haven, CT 06520 8031, USA
    J Rheumatol 37:1236-43. 2010
    ..To systematically review the literature on reported adverse effects (AE) associated with use of topical nonsteroidal antiinflammatory drugs (NSAID) in older adults with osteoarthritis (OA)...
  32. pmc What is most important to patients when deciding about colorectal screening?
    Avlin Imaeda
    Clinical Epidemiology Research Center, VA CT Healthcare System, West Haven, CT, USA
    J Gen Intern Med 25:688-93. 2010
    ..Colorectal cancer (CRC) screening can be administered through tests with varied characteristics and is a preference-sensitive decision...
  33. pmc Medical decision making in patients with knee pain, meniscal tear, and osteoarthritis
    Lisa G Suter
    Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, 300 Cedar Street, Room TAC S541, PO Box 208031, New Haven, CT 06520 8031, USA
    Arthritis Rheum 61:1531-8. 2009
    ..Our objective was to evaluate the capability of preoperative information to predict APM outcomes in OA...
  34. pmc Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes
    Mary E Tinetti
    Department of Internal Medicine and Epidemiology, New Haven, Connecticut 06504, USA
    J Am Geriatr Soc 56:1409-16. 2008
    ..To determine the priority that older adults with coexisting hypertension and fall risk give to optimizing cardiovascular outcomes versus fall- and medication symptom-related outcomes...
  35. ncbi request reprint What factors account for referral delays for patients with suspected rheumatoid arthritis?
    Lisa G Suter
    VA Connecticut Healthcare System, and Yale University School of Medicine, IE 61 SHM, c o RWJ CSP, PO Box 208088, New Haven, CT 06520 8088, USA
    Arthritis Rheum 55:300-5. 2006
    ..Our objective was to explore the factors influencing the decision of a primary care physician (PCP) to refer or not refer a patient with suspected RA, and to identify modifiable factors influencing timely referral...
  36. ncbi request reprint The incidence and natural history of Raynaud's phenomenon in the community
    Lisa G Suter
    Yale University School of Medicine, New Haven, Connecticut 06520 8088, USA
    Arthritis Rheum 52:1259-63. 2005
    ..Our objective was to determine the incidence and natural history of RP not associated with a connective tissue disease in a large, community-based population...
  37. ncbi request reprint Smoking, alcohol consumption, and Raynaud's phenomenon in middle age
    Lisa G Suter
    VA Connecticut Healthcare System, West Haven, Conn, USA
    Am J Med 120:264-71. 2007
    ..Our objective was to determine whether smoking and alcohol are independently associated with Raynaud's in a large, community-based cohort...
  38. pmc Inconsistency over time in the preferences of older persons with advanced illness for life-sustaining treatment
    Terri R Fried
    Clinical Epidemiology Research Center, VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA
    J Am Geriatr Soc 55:1007-14. 2007
    ..To determine whether preferences for future attempts at life-sustaining treatment change over time in a consistent and predictable manner...
  39. doi request reprint Cost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management
    Lisa G Suter
    Section of Rheumatology, Department of Internal Medicine, Yale University School of Medicine, 300 Cedar St, Room TAC S541, PO Box 208031, New Haven, CT 06520 8031, USA
    Arch Intern Med 171:657-67. 2011
    ..Our objective was to determine the incremental cost-effectiveness of adding MRI to standard risk stratification in early RA...
  40. pmc Informed consent for abdominal aortic aneurysm repair: assessing variations in surgeon opinion through a national survey
    Loren Berman
    Yale University School of Medicine, New Haven, CT 06520, USA
    J Vasc Surg 47:287-295. 2008
    ..This study examines expert opinion regarding what constitutes informed consent...
  41. pmc Development of a tool for eliciting patient priority from among competing cardiovascular disease, medication-symptoms, and fall injury outcomes
    Mary E Tinetti
    Department of Medicine, Section of Geriatrics, New Haven, Connecticut 06520 8025, USA
    J Am Geriatr Soc 56:730-6. 2008
    ..To develop a choice task for eliciting priorities in the face of competing cardiovascular disease (CVD) outcomes, medication-related symptoms, and fall injuries...
  42. pmc Informed consent for abdominal aortic aneurysm repair: The patient's perspective
    Loren Berman
    Yale University School of Medicine, New Haven, Conn, USA
    J Vasc Surg 48:296-302. 2008
    ..This study explores patients' views on their decision-making processes and the quality of surgeon-patient communication during informed consent for AAA repair...
  43. pmc Pilot testing of a decision support tool for patients with abdominal aortic aneurysms
    Loren Berman
    Department of Surgery, Yale University School of Medicine, Robert Wood Johnson Clinical Scholars Program, New Haven, Conn 06520, USA
    J Vasc Surg 53:285-92.e1. 2011
    ..The objective of this study was to develop and pilot test a decision support tool for patients with AAAs...
  44. ncbi request reprint Raynaud's phenomenon: epidemiology and risk factors
    Liana Fraenkel
    Yale University, Department of Internal Medicine, Section of Rheumatology, PO Box 208031, 333 Cedar Street, New Haven, CT 06520 8031, USA
    Curr Rheumatol Rep 4:123-8. 2002
    ..Dr. Maricq was the first to develop and validate a standardized instrument to classify patients with this disorder. Her work has facilitated many of the epidemiologic studies of RP that are discussed in this review...
  45. ncbi request reprint Improving the selective use of plain radiographs in the initial evaluation of shoulder pain
    L Fraenkel
    Yale University School of Medicine, Division of Rheumatology, Arthritis Center, Boston, Massachusetts, USA
    J Rheumatol 27:200-4. 2000
    ..Our objective was to prospectively define clinical criteria that identify patients who have a low risk of radiographic findings that influence the management of the initial evaluation of shoulder pain in the emergency department...
  46. pmc A pilot project examining the predicted preferences of patients and physicians in the primary prophylaxis of variceal hemorrhage
    Anna V Longacre
    Section of Digestive Disease, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
    Hepatology 47:169-76. 2008
    ..Physicians should discuss both EVL and beta-blockers with patients requiring primary prophylaxis for variceal hemorrhage. Future guidelines should incorporate individual patient preferences...
  47. ncbi request reprint Patient preferences for treatment of lupus nephritis
    Liana Fraenkel
    Yale University, New Haven, Connecticut and Veterans Administration Connecticut Healthcare System, West Haven, Connecticut 06520 8031, USA
    Arthritis Rheum 47:421-8. 2002
    ..To examine the amount of improvement in renal survival that lupus patients require before choosing cyclophosphamide over azathioprine for the treatment of lupus nephritis...

Research Grants2

  1. Eliciting Patient Treatment Preferences for Osteoporosis
    Liana Fraenkel; Fiscal Year: 2007
    ..abstract_text> ..